These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8769215)

  • 1. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
    Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
    Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
    Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
    Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 6. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
    Lagget M; Marzano A; Actis GC; Leone N; Ciancio A; Salizzoni M; Rizzetto M
    Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
    Scott JS; Boyle GJ; Daubeney PE; Miller SA; Law Y; Pigula F; Griffith BP; Webber SA
    Transplant Proc; 1999; 31(1-2):82-3. PubMed ID: 10083017
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
    Bilbao I; Parrilla P; Rimola A; Figueras J; Fabrega E; Gomez M; De Vicente E; Margarit C
    Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of Neoral in pediatric liver transplantation.
    Whitington PF; Alonso EM; Millis JM
    Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
    Baruch Y; Assy N; Kramsky R; Enat R
    Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
    Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
    Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
    Falkenstein K; Dunn S
    Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354
    [No Abstract]   [Full Text] [Related]  

  • 14. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
    Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
    Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
    Gridelli B; Colledan M; Lucianetti A; Ulla L; Riva S; Segalin A; Fassati LR; Torre G
    Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM; Conort O; Conti F; Bernard D; Hazebroucq G; Calmus Y
    Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
    Dunn SP; Falkenstein K; Pierson A; Cooney GF
    Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
    Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
    Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
    Pinson CW; Beauregard-Zollinger L
    Transplant Proc; 1996 Aug; 28(4):2234-6. PubMed ID: 8769209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.